553
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis

, , , , , & show all
Pages 351-358 | Received 30 Oct 2009, Accepted 24 Nov 2009, Published online: 26 Jan 2010

References

  • ten Cate JW, van der Poll T, Levi M, ten Cate H, van Deventer SJ. Cytokines: triggers of clinical thrombotic disease. Thromb Haemost 1997;78:415–9.
  • Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, . Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890–7.
  • Jin T, Bokarewa M, Tarkowski A. Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis 2005;192:429–37.
  • Syrovets T, Tippler B, Rieks M, Simmet T. Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood 1997;89:4574–83.
  • Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996;15:252–9.
  • Burysek L, Syrovets T, Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 2002;277:33509–17.
  • Plow EF, Ploplis VA, Busuttil S, Carmeliet P, Collen D. A role of plasminogen in atherosclerosis and restenosis models in mice. Thromb Haemost 1999;82(Suppl 1):4–7.
  • Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997;89:1111–9.
  • Nordstrand A, Shamaei-Tousi A, Ny A, Bergstrom S. Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. Infect Immun 2001;69:5832–9.
  • Guo Y, Li J, Hagstrom E, Ny T. Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. Arthritis Rheum 2008;58:764–72.
  • Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301–11.
  • Bremell T, Lange S, Holmdahl R, Ryden C, Hansson GK, Tarkowski A. Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun 1994;62:2334–44.
  • Bremell T, Lange S, Svensson L, Jennische E, Grondahl K, Carlsten H, . Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990;33:1739–44.
  • Stiles BG, Campbell YG, Castle RM, Grove SA. Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1. Infect Immun 1999;67:1521–5.
  • Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun 1991;59:2615–23.
  • Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988;18:1535–40.
  • Silberman S, Bernik MB, Potter EV, Kwaan HC. Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity. Br J Haematol 1973;24:101–13.
  • Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996;5:223–8.
  • Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, . Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004;126:1087–92.
  • Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, . Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004;305:1283–6.
  • Ott I, Malcouvier V, Schomig A, Neumann FJ. Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction. Circulation 2002;105:279–81.
  • Tang H, Ivanciu L, Popescu N, Peer G, Hack E, Lupu C, . Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol 2007;171:1066–77.
  • Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317–43.
  • Czura CJ, Yang H, Amella CA, Tracey KJ. HMGB1 in the immunology of sepsis (not septic shock) and arthritis. Adv Immunol 2004;84:181–200.
  • Okabayashi K, Wada H, Ohta S, Shiku H, Nobori T, Maruyama K. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol 2004;76:225–9.
  • Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost 2001;86:543–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.